Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q2 2024 Earnings

9MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-1.06

-0.71

-0.35

0

Details

Expected EPS

-0.617915

Actual EPS

-1.06

Surprise EPS

-0.44

Surprise Percent

+71.54%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -1.06 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.